相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up
Kerri A. Ohman et al.
HPB (2017)
Interferon-based Adjuvant Chemoradiation for Resected Pancreatic Head Cancer Long-term Follow-up of the Virginia Mason Protocol
Flavio G. Rocha et al.
ANNALS OF SURGERY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017
Aimee L. Lucas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
J. Bart Rose et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Taxanes: impact on pancreatic cancer
E. Gabriela Chiorean et al.
ANTI-CANCER DRUGS (2014)
Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
Svetlana Karakhanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response
O. Turrini et al.
EJSO (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
Jean-Luc Van Laethem et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Strength of the evidence: Adjuvant therapy for resected pancreatic cancer
Vincent J. Picozzi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Curative resection is the single most important factor determing outcome in patients with pancreatic adenocarcinoma
M Wagner et al.
BRITISH JOURNAL OF SURGERY (2004)
Gemcitabine combined with docetaxel for the treatment of unresectable pancreatic carcinoma
AD Jacobs et al.
CANCER INVESTIGATION (2004)
Preclinical pharmacology of the taxanes: Implications of the differences
J Gligorov et al.
ONCOLOGIST (2004)
Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma
VJ Picozzi et al.
AMERICAN JOURNAL OF SURGERY (2003)
分享论文
